Impact of Combined "CHADS-BLED" Score to Predict Short-Term Outcomes in Transfemoral and Transapical Aortic Valve Replacement.
Verena VeulemansOliver MaierGeorg BosbachKatharina HellhammerShazia AfzalKerstin PiaydaAmin PolzinChristian JungRalf WestenfeldArash MehdianiArtur LichtenbergMalte KelmTobias ZeusPublished in: Journal of interventional cardiology (2020)
The combined CHADS-BLED score was a strong predictor for 30-day mortality in TF TAVR patients with AF. A high CHADS-BLED score showed a good predictive value for major vascular and bleeding events as well as CVI in TF TAVR patients. This study is registered at clinical trials (NCT01805739).
Keyphrases
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- ejection fraction
- aortic valve
- clinical trial
- end stage renal disease
- atrial fibrillation
- newly diagnosed
- left ventricular
- chronic kidney disease
- prognostic factors
- type diabetes
- randomized controlled trial
- coronary artery disease
- peritoneal dialysis
- patient reported outcomes
- study protocol
- open label